Last reviewed · How we verify

NCT03379519

Protocol of Multi-domain Attention Training

Completed NA Last updated 20 February 2020
What this trial tests

NA trial testing Multi-domain Attention Training (MAT) in Mild Cognitive Impairment in 60 participants. Completed in 31 December 2019.

Timeline
1 August 2016
Primary endpoint
31 May 2019
31 December 2019

Quick facts

Lead sponsorMinistry of Science and Technology, Taiwan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment60
Start date1 August 2016
Primary completion31 May 2019
Estimated completion31 December 2019

Drugs / interventions tested

Conditions studied

Sponsor

Ministry of Science and Technology, Taiwan

Who can join

Eligibility, any sex, with Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study sought to investigate the changes in attention in older adults with mild cognitive impairment after Multi-domain Attention Training .

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Mild Cognitive Impairment

Currently open trials in the same condition.

Other Ministry of Science and Technology, Taiwan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03379519.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing